GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

The global immunohistochemistry market is anticipated to grow at a CAGR of 7.93% during the years 2018-2026. Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques in order to image and localize discrete components in tissues with the help of antibodies-antigen interaction.

GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026

Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents, Kits) by Applications (Diagnostics, Testing) by End Users (Hospitals and Diagnostic Laboratories, Research Institutes, Other End-users) & by Geography.

Request free sample

The global immunohistochemistry market is anticipated to grow at a CAGR of 7.93% during the years 2018-2026. Immunohistochemistry (IHC) is an umbrella term which combines immunological, biochemical and anatomical techniques in order to image and localize discrete components in tissues with the help of antibodies-antigen interaction.

The global immunohistochemistry market is primarily driven by following factors:

  • Rising cancer incidence
  • Technological expansions in in-vitro diagnostic commerce
  • Increasing elderly population
  • Increasing healthcare spending
  • Growing popularity of POC testing

immunohistochemistry market

To know more about this report, request a free sample copy

The important drivers increasing growth in the global immunohistochemistry market are increasing elderly population and increasing healthcare spending. The geriatric population is rapidly increasing across the globe. According to World Health Organization (WHO), the elderly population is expected to reach nearly 2 billion by 2050. Healthcare spending is increasing as a result of increasing prevalence of diseases, rise in geriatric population and growing demand for quality healthcare.

The products of immunohistochemistry market are used extensively for various purposes. An antibody is known as an immunoglobulin, basically, a large Y-shaped protein produced by plasma cells that are used by the immune system to neutralize pathogens such as viruses and pathogenic bacteria. Primary antibody can bind to a biomolecule of interest, or a precise protein is known as a primary antibody. In the process of diagnostic and drug testing, various immunohistochemistry equipments are used such as Slide Staining Systems, Tissue Microarrays (TMA), Tissue Processing Systems, Slide Scanners and Other Equipment (Microtome, Water Bath, pH meter). The reagents segment is sub-divided into Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, and Diluents. Immunohistochemistry kits are a complete package of antibodies, dilution reagents, substrates, and blocking buffers.

Presence of an undiagnosed population along with no insurance coverage and reimbursement issues are the major factors hindering the growth of the immunohistochemistry market. In developed countries, the ratio of diagnosed and the undiagnosed population is 4:1, in developing countries, it is 1:4, which shows the lack of awareness regarding proper testing and diagnosis among the developing region’s population. The low level of reimbursements and the insufficient insurance coverage associated with treatments discourage people from undergoing anatomic pathology and tissue diagnostic-based therapies. Instead, individuals are opting for alternate conventional therapies.

The global immunohistochemistry market segments include products, end-users, and applications.

Products are segmented into:

  • Antibodies
    • Primary antibodies
    • Secondary antibodies
  • Equipment
  • Slide staining systems
  • Tissue microarrays
  • Tissue processing systems
  • Slide scanners
  • Other equipment’s
  • Reagents
  • Chromogenic substrates
  • Histological stains
  • Organic solvents
  • Fixation reagents
  • Stabilizers
  • Blocking sera and reagents
  • Diluents
  • Proteolytic enzymes
  • Kits

End users are segmented into:

  • Hospitals and diagnostic laboratories
  • Research institutes
  • Other end users

Applications are segmented into:

  • Diagnostics
  • Cancer
  • Infectious diseases
  • Cardiovascular disease
  • Autoimmune diseases
  • Diabetes mellitus
  • Nephrological diseases
  • Drug testing

This report covers the present market conditions and the growth prospects of the global immunohistochemistry market for 2018-2026 and considered the revenue generated through the sales of immunohistochemistry for types, applications and end-user to calculate the market size by considering the base year as 2017.

Geographically, the global immunohistochemistry market has been segmented on the basis of four major regions, which include:

The immunohistochemistry market in North America is expected to hold the largest share by 2026. The United States immunohistochemistry market is developing and expanding at a significant pace. The escalating prevalence of autoimmune diseases along with the prevalence of cancer in the country drives the United States immunohistochemistry market. Canada immunohistochemistry market is anticipated to upsurge, owing to the rising incidences of cancer in the country. The incidence of cancer in Canada is prevalent making it one of the leading countries with a high number of cancer cases in the North American region. On the other hand, Asia-Pacific market is anticipated to be the fastest-growing region for the immunohistochemistry market. Academic research in China is on the constant rise as it is well funded & substantial precision medicine initiative is also taken up by the Chinese government. The constant rise in the prevalence of cancer in China is acting as a key driver in the growth of immunochemistry market in the country. The government report stated that the old-age dependency ratio has climbed from 10.9 percent in the year 1961 to 14.2 percent in 2011 for India as a whole is further augmenting the growth of immunohistochemistry market.

The immunohistochemistry market by end-users is sub-divided into hospitals and diagnostic laboratories, research institutes and other end-users. The applications segment is sub-divided into diagnostics & drug testing. Immunohistochemistry is an ancillary method that is often used in many hospitals and diagnostic laboratories. It is also a helpful method that is often used for research purposes in many research institutes. Other applications include contract research organization and forensic laboratories. IHC is more beneficial over the conventional enzyme staining methods, as its process includes definite antigen-antibody reactions. Immunohistochemistry (IHC) is a method to identify cellular and tissue antigens through antibody reactions.

The major market players in the global immunohistochemistry market are:

  • ABBOTT LABORATORIES
  • ABCAM PLC
  • BIOGENEX
  • CELL SIGNALING TECHNOLOGY, INC.
  • DANAHER CORPORATION

Company Profiles covers analysis of important players.

Abbott Laboratories is a U.S. based company headquartered in Illinois. The company discovers, develop, manufacture and sell a line of healthcare products. Danaher Corporation is a US based company having headquarters in Washington, DC. The company was established in 1969. The company provides medical, industrial and commercial products and services which shows a character of the strong brand.

Key Findings of the global immunohistochemistry market:

  • North America dominated the immunohistochemistry market
  • Reagents products are growing at a significant rate
  • Diagnostics is the most widely used application in the market
  • Hospitals and diagnostic laboratories hold the largest market share in the end-users market
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • NORTH AMERICA DOMINATED THE IMMUNOHISTOCHEMISTRY MARKET
      • REAGENTS PRODUCTS ARE GROWING AT A SIGNIFICANT RATE
      • DIAGNOSTICS IS THE MOST WIDELY USED APPLICATION IN THE MARKET
      • HOSPITALS AND DIAGNOSTIC LABORATORIES HOLDS THE LARGEST MARKET SHARE IN THE END-USERS MARKET
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • RISING CANCER INCIDENCE
      • TECHNOLOGICAL EXPANSIONS IN IN-VITRO DIAGNOSTIC COMMERCE
      • INCREASING ELDERLY POPULATION
      • INCREASING HEALTHCARE SPENDING
      • GROWING POPULARITY OF POC TESTING
    • MARKET RESTRAINTS
      • INSURANCE COVERAGE AND REIMBURSEMENT ISSUES
      • LIMITATIONS OF CLOSED SYSTEMS
      • PRESENCE OF AN UNDIAGNOSED POPULATION
    • MARKET OPPORTUNITIES
      • USE OF BIOMARKERS FOR DISEASE DIAGNOSIS AND INCREASING EFFICIENCY
      • PARADIGM SHIFT TOWARD PRECISION DIAGNOSIS THROUGH PERSONALIZED MEDICINE
      • ADVANCEMENTS IN TECHNOLOGIES
    • MARKET CHALLENGES
      • HIGH INITIAL INVESTMENT AND MAINTENANCE COST
      • STRINGENT REGULATION FOR APPROVAL OF DEVICES
      • PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION
  1. MARKET SEGMENTATION
    • MARKET BY PRODUCTS 2018-2026
      • ANTIBODIES
        • PRIMARY ANTIBODIES
        • SECONDARY ANTIBODIES
      • EQUIPMENT
        • SLIDE STAINING SYSTEMS
        • TISSUE MICROARRAYS
        • TISSUE PROCESSING SYSTEMS
        • SLIDE SCANNERS
        • OTHER EQUIPMENTS
      • REAGENTS
        • HISTOLOGICAL STAINS
        • BLOCKING SERA AND REAGENTS
        • CHROMOGENIC SUBSTRATES
        • FIXATION REAGENTS
        • STABILIZERS
        • ORGANIC SOLVENTS
        • PROTEOLYTIC ENZYMES
        • DILUENTS
      • KITS
    • MARKET BY APPLICATIONS 2018-2026
      • DIAGNOSTICS
        • CANCER
        • INFECTIOUS DISEASES
        • CARDIOVASCULAR DISEASE
        • AUTOIMMUNE DISEASES
        • DIABETES MELLITUS
        • NEPHROLOGICAL DISEASES
      • DRUG TESTING
    • MARKET BY END-USERS 2018-2026
      • HOSPITALS AND DIAGNOSTIC LABORATORIES
      • RESEARCH INSTITUTES
      • OTHER END-USERS
  1. KEY ANALYTICS
    • IMMUNOHISTOCHEMISTRY ETYMOLOGY
    • REGULATORY FRAMEWORKS
      • REGULATIONS IN THE UNITED STATES
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL SUPPLIERS
      • MANUFACTURERS
      • DISTRIBUTORS
      • END-USERS
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
    • LATIN AMERICA
      • BRAZIL
      • MEXICO
      • ARGENTINA
      • CHILE
      • CUBA
      • REST OF LATIN AMERICA
    • REST OF WORLD
      • MIDDLE EAST AND NORTH AFRICA
      • REST OF AFRICA
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
      • COMPANY PROFILE
      • PRODUCT PORTFOLIO
      • SWOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ABCAM PLC
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • AGILENT TECHNOLOGIES, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BIOGENEX
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • BIO-RAD LABORATORIES, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • BIO SB
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • CELL SIGNALING TECHNOLOGY, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • DANAHER CORPORATION
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • HOFFMANN-LA ROCHE AG
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • HISTOLOGIX
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
    • MERCK MILLIPORE
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • STRATEGIC INITIATIVES
    • PERKINELMER, INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • SIEMENS AG HEALTHCARE
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • THERMO FISHER SCIENTIFIC INC.
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES

 

LIST OF TABLES

TABLE 1       GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 2       CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 3       POPULATION AGED 60 YEARS AND ABOVE

TABLE 4       POPULATION AGED 80 YEARS AND ABOVE

TABLE 5       COUNTRIES WITH UTMOST AGED POPULATION

TABLE 6       GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2018-2026 ($ MILLION)

TABLE 7       GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 8       INCIDENCE OF DIABETES IN MAJOR COUNTRIES, 2016 ($ MILLIONS)

TABLE 9       GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES -2026 ($ MILLION)

TABLE 10     GLOBAL ANTIBODIES MARKET IN PRIMARY ANTIBODIES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 11     CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 12     GLOBAL ANTIBODIES MARKET IN SECONDARY ANTIBODIES GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 13     SECONDARY ANTIBODY SELECTION

TABLE 14     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 15     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

TABLE 16     GLOBAL EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 17     GLOBAL EQUIPMENT MARKET IN TISSUE MICROARRAYS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 18     GLOBAL EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 19     HEALTHCARE SPENDING BY HIGH-INCOME COUNTRIES BY 2040

TABLE 20     GLOBAL EQUIPMENT MARKET IN SLIDE SCANNERS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 21     GLOBAL EQUIPMENT MARKET IN OTHER EQUIPMENT’S BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 22     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 23     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

TABLE 24     GLOBAL REAGENTS MARKET IN HISTOLOGICAL STAINS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 25     HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 26     GLOBAL REAGENTS MARKET IN BLOCKING SERA AND REAGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 27     GLOBAL REAGENTS MARKET IN CHROMOGENIC SUBSTRATES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 28     GLOBAL REAGENTS MARKET IN FIXATION REAGENTS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 29     COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 30     GLOBAL REAGENTS MARKET IN STABILIZERS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 31     GLOBAL REAGENTS MARKET IN ORGANIC SOLVENTS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 32     GLOBAL REAGENTS MARKET IN PROTEOLYTIC ENZYMES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 33     GLOBAL REAGENTS MARKET IN DILUENTS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 34     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN KITS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 35     KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

TABLE 36     GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2018-2026 ($ MILLION)

TABLE 37     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 38     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

TABLE 39     GLOBAL DIAGNOSTIC MARKET IN CANCER BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 40     GLOBAL DIAGNOSTIC MARKET IN INFECTIOUS DISEASES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 41     GLOBAL DIAGNOSTIC MARKET IN CARDIOVASCULAR DISEASE BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 42     GLOBAL DIAGNOSTIC MARKET IN AUTOIMMUNE DISEASES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 43     SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 44     GLOBAL DIAGNOSTIC MARKET IN DIABETES MELLITUS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 45     GLOBAL DIAGNOSTIC MARKET IN NEPHROLOGICAL DISEASES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 46     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 47     GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2018-2026 ($ MILLION)

TABLE 48     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 49     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 50     CANCER RESEARCH PROGRAM

TABLE 51     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 52     IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY

TABLE 53     ANTIBODIES MANUFACTURERS IN THE GLOBAL IMMUNOHISTOCHEMISTRY MARKET

TABLE 54     GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)

TABLE 55     NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 56     FUND INVESTED FOR DIFFERENT CANCER TYPES (2017)

TABLE 57     PERCENT DISTRIBUTION OF PROJECTED NEW CANCER CASES (2017)

TABLE 58     EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 59     NUMBER OF PEOPLE LIVING AND DYING WITH CVD

TABLE 60     NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR DISEASES IN GERMANY 2016

TABLE 61     DISEASES CAUSING PREMATURE DEATH IN GERMANY (2017)

TABLE 62     ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 63     CANCER TYPES BASED ON INCIDENCE RATES (2016)

TABLE 64     CANCER TYPES BASED ON MORTALITY RATES (2016)

TABLE 65     ESTIMATED INCIDENCE OF ALL CANCERS COMBINED BY SEX (2017)

TABLE 66     ESTIMATED COMMON CAUSES OF DEATH FOR CANCER (MALES 2017)

TABLE 67     ESTIMATED COMMON CAUSES OF DEATH FOR CANCER BY SEX (FEMALES 2017)

TABLE 68     LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

TABLE 69     CAUSES OF DEATH IN ARGENTINA IN 2016

TABLE 70     CAUSES OF DEATH IN CUBA 2016

TABLE 71     REST OF WORLD IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

LIST OF FIGURES

FIGURE 1     GLOBAL IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 2     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2018-2026 ($ MILLION)

FIGURE 3     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2018-2026 ($ MILLION)

FIGURE 4     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2018-2026 ($ MILLION)

FIGURE 5     PHASES OF HISTOLOGICAL STAINING

FIGURE 6     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN KITS 2018-2026 ($ MILLION)

FIGURE 7     GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTIC 2018-2026 ($ MILLION)

FIGURE 8     HEALTHCARE EXPENDITURES ACROSS THE GLOBE (% OF GDP)

FIGURE 9     GLOBAL PREVALENCE OF CHRONIC KIDNEY DISEASES BY AGE

FIGURE 10   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2018-2026 ($ MILLION)

FIGURE 11   INCIDENCE OF PATIENTS WITH CHRONIC DISEASES GLOBALLY 2005–2030

FIGURE 12   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2018-2026 ($ MILLION)

FIGURE 13   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2018-2026 ($ MILLION)

FIGURE 14   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2018-2026 ($ MILLION)

FIGURE 15   HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 16   NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 17   THE UNITED STATES IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 18   CANADA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 19   EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 20   THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 21   FRANCE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 22   GERMANY IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 23   SPAIN IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 24   ITALY IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 25   RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 26   REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 27   ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 28   CHINA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 29   INDIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 30   JAPAN IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 31   SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 32   AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 33   REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 34   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 35   BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 36   HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($ BILLION)

FIGURE 37   MEXICO IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 38   HEALTHCARE SPENDING IN ARGENTINA 2014 AND 2040 ($ BILLION)

FIGURE 39   ARGENTINA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 40   CHILE IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 41   HEALTHCARE EXPENDITURE IN CHILE 2005-2016 (PERCENTAGE SHARE OF GDP)

FIGURE 42   HEALTHCARE SPENDING IN CUBA (2014 AND 2040)

FIGURE 43   CUBA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 44   REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 45   REST OF WORLD IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 46   MIDDLE EAST AND NORTH AFRICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

FIGURE 47   REST OF AFRICA IMMUNOHISTOCHEMISTRY MARKET 2018-2026 ($ MILLION)

  1. MARKET SEGMENTATION
    • MARKET BY PRODUCTS 2018-2026
      • ANTIBODIES
        • PRIMARY ANTIBODIES
        • SECONDARY ANTIBODIES
      • EQUIPMENT
        • SLIDE STAINING SYSTEMS
        • TISSUE MICROARRAYS
        • TISSUE PROCESSING SYSTEMS
        • SLIDE SCANNERS
        • OTHER EQUIPMENT’S
      • REAGENTS
        • HISTOLOGICAL STAINS
        • BLOCKING SERA AND REAGENTS
        • CHROMOGENIC SUBSTRATES
        • FIXATION REAGENTS
        • STABILIZERS
        • ORGANIC SOLVENTS
        • PROTEOLYTIC ENZYMES
        • DILUENTS
      • KITS
    • MARKET BY APPLICATIONS 2018-2026
      • DIAGNOSTICS
        • CANCER
        • INFECTIOUS DISEASES
        • CARDIOVASCULAR DISEASE
        • AUTOIMMUNE DISEASES
        • DIABETES MELLITUS
        • NEPHROLOGICAL DISEASES
      • DRUG TESTING
    • MARKET BY END USERS 2018-2026
      • HOSPITALS AND DIAGNOSTIC LABORATORIES
      • RESEARCH INSTITUTES
      • OTHER END USERS
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • ASIA-PACIFIC
      • CHINA
      • INDIA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
    • LATIN AMERICA
      • BRAZIL
      • MEXICO
      • ARGENTINA
      • CHILE
      • CUBA
      • REST OF LATIN AMERICA
    • REST OF WORLD
      • MIDDLE EAST AND NORTH AFRICA
      • REST OF AFRICA

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now